ABBV - AbbVie Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
130.14B
Enterprise Value 3
158.33B
Trailing P/E
40.42
Forward P/E 1
9.27
PEG Ratio (5 yr expected) 1
2.68
Price/Sales (ttm)
3.96
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
4.82
Enterprise Value/EBITDA 6
10.24

Trading Information

Stock Price History

Beta (5Y Monthly) 0.95
52-Week Change 30.68%
S&P500 52-Week Change 325.98%
52 Week High 391.99
52 Week Low 362.66
50-Day Moving Average 388.54
200-Day Moving Average 376.97

Share Statistics

Avg Vol (3 month) 37.42M
Avg Vol (10 day) 38.56M
Shares Outstanding 51.48B
Float 1.48B
% Held by Insiders 10.09%
% Held by Institutions 175.71%
Shares Short (Dec 30, 2019) 471.95M
Short Ratio (Dec 30, 2019) 410.64
Short % of Float (Dec 30, 2019) 45.52%
Short % of Shares Outstanding (Dec 30, 2019) 44.87%
Shares Short (prior month Nov 28, 2019) 468.4M

Dividends & Splits

Forward Annual Dividend Rate 44.72
Forward Annual Dividend Yield 45.29%
Trailing Annual Dividend Rate 34.28
Trailing Annual Dividend Yield 34.79%
5 Year Average Dividend Yield 43.72
Payout Ratio 4183.70%
Dividend Date 3Feb 13, 2020
Ex-Dividend Date 4Jan 13, 2020
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 9.90%
Operating Margin (ttm)41.11%

Management Effectiveness

Return on Assets (ttm)13.45%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)32.87B
Revenue Per Share (ttm)22.15
Quarterly Revenue Growth (yoy)3.00%
Gross Profit (ttm)25.04B
EBITDA 15.46B
Net Income Avi to Common (ttm)3.23B
Diluted EPS (ttm)2.18
Quarterly Earnings Growth (yoy)-31.40%

Balance Sheet

Total Cash (mrq)10.65B
Total Cash Per Share (mrq)7.2
Total Debt (mrq)38.84B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.15
Book Value Per Share (mrq)-5.56

Cash Flow Statement

Operating Cash Flow (ttm)13.44B
Levered Free Cash Flow (ttm)10.29B